Track NVAX and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Novavax Inc
21 Firstfield Road, Gaithersburg, MD, United States, 20878
IPO
1995
Employees
749
Industry
Biotechnology
Sector
Healthcare
Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Insider Transactions
Quarterly buy vs. sell activity
Sell (left)Buy (right)
Q4 20243-3
0
Q2 20243-3
0
2-quarter cumulative
6 sells0 buys
Analyst Ratings
3 analysts covering
Sell67%recommend sell
Buy
0
Hold
1
Sell
2